ヌクレオチドの市場規模、シェア、動向分析レポート：製品別、技術別、用途別、地域別、セグメント予測、2023年～2030年

ヌクレオチド市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のヌクレオチド市場規模は2023年から2030年にかけて7.12%のCAGRを記録し、2030年には13億7,725万米ドルに達すると予測されています。

世界のヌクレオチド市場は、医薬品や飲食品産業で広く使用されているため、予測期間中に大幅な成長が見込まれています。診断研究と医薬品用途は、免疫力強化、腸への好影響、ストレスからの回復への好影響などの特性により、ヌクレオチド市場を独占しています。さらに、家畜栄養のための酵母由来のヌクレオチドと相まって、食物ヌクレオチド分野の研究開発が世界中で拡大しており、予測期間中の需要を促進すると期待されています。

ヌクレオチド市場レポートハイライト

• 2022年の世界市場は、TaqMan対立遺伝子識別セグメントが支配的で、パイロシーケンスによるSNPがこれに続いた。
• 診断研究セグメントが2022年のヌクレオチド世界市場を独占。
• デオキシヌクレオチド（dNTPs）セグメントは、2022年に47.49％の収益シェアで世界のヌクレオチド市場を独占し、さらに予測期間中に7.34％の最速CAGRで拡大する可能性が高いです。
• アジア太平洋は、他の地域の中で最も速い成長を示し、2023年から2030年までのCAGR 7.81％で成長すると予想されています。同地域には大手ヌクレオチドメーカーが存在し、栄養補助食品や健康食品業界の需要増と相まって、同製品の需要増が見込まれています。また、特にアジア太平洋地域における飲食品添加物の探求の増加は、予測期間にわたってヌクレオチドの市場成長を促進する可能性が高いです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヌクレオチド市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ヌクレオチド市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 ヌクレオチド市場：製品推定・動向分析

• ヌクレオチド市場：重要なポイント
• ヌクレオチド市場：製品動向と市場シェア分析、2022年および2030年
• デオキシヌクレオチド
• ジデオキシヌクレオチド
• RNA合成のためのヌクレオチド（rNTP）
• 標識ヌクレオチド

第5章 ヌクレオチド市場：技術推定・動向分析

• ヌクレオチド市場：重要なポイント
• ヌクレオチド市場：技術動向と市場シェア分析、2022年および2030年
• TaqMan対立遺伝子識別
• 遺伝子チップとマイクロアレイ
• パイロシークエンシングによるSNP
• その他

第6章 ヌクレオチド市場：アプリケーションの推定・動向分析

• ヌクレオチド市場：重要なポイント
• ヌクレオチド市場：アプリケーションの動きと市場シェア分析、2022年と2030年
• 医薬品
• 診断調査
• 飲食品添加物
• 動物飼料添加物
• その他

第7章 ヌクレオチド市場：地域推定・動向分析

• 地域別の展望
• 地域別のヌクレオチド市場：重要なポイント
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • CJ CHEILJEDANG CORP
  • Star Lake Bioscience Co., Inc.
  • Thermo Fisher Scientific Inc.
  • MEIHUA HOLDINGS GROUP CO., LTD.
  • F. Hoffmann-La Roche Ltd.
  • Biorigin
  • DSM Nutritional Products AG
  • Promega Corporation
  • Agilent Technologies Inc.
  • Lallemand Inc.
  • Nanjing Biotogether Co., Ltd.
  • NuEra Nutraceuticals Inc.
  • Ohly

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 3 North America nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 4 North America nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 5 North America nucleotides market, by region, 2018 - 2030 (USD Million)
• Table 6 U.S. nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 8 U.S. nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 9 Canada nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 11 Canada nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 12 Europe nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 13 Europe nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 14 Europe nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 15 Europe nucleotides market, by region, 2018 - 2030 (USD Million)
• Table 16 Germany nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 17 Germany nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 18 Germany nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 19 UK nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 20 UK nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 21 UK nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 22 France nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 23 France nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 24 France nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 25 Italy nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 26 Italy nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 27 Italy nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 28 Spain nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 29 Spain nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 30 Spain nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 31 Denmark nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 32 Denmark nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 33 Denmark nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 34 Sweden nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 35 Sweden nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 36 Sweden nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 37 Norway nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 38 Norway nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 39 Norway nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific nucleotides market, by region, 2018 - 2030 (USD Million)
• Table 44 Japan nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 45 Japan nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 46 Japan nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 47 China nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 48 China nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 49 China nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 50 India nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 51 India nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 52 India nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 53 Australia nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 54 Australia nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 55 Australia nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 56 Thailand nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 57 Thailand nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 58 Thailand nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 59 South Korea nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 60 South Korea nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 61 South Korea nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 62 Latin America nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 63 Latin America nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 64 Latin America nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 65 Latin America nucleotides market, by region, 2018 - 2030 (USD Million)
• Table 66 Brazil nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 67 Brazil nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 68 Brazil nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 69 Mexico nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 70 Mexico nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 71 Mexico nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 72 Argentina nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 73 Argentina nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 74 Argentina nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 77 Middle East and Africa nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 78 Middle East and Africa nucleotides market, by region, 2018 - 2030 (USD Million)
• Table 79 South Africa nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 80 South Africa nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 81 South Africa nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 85 UAE nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 86 UAE nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 87 UAE nucleotides market, by application, 2018 - 2030 (USD Million)
• Table 88 Kuwait nucleotides market, by product, 2018 - 2030 (USD Million)
• Table 89 Kuwait nucleotides market, by technology, 2018 - 2030 (USD Million)
• Table 90 Kuwait nucleotides market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 QFD modeling for market share assessment
• Fig. 6 Market formulation & validation
• Fig. 7 Nucleotides: Market outlook
• Fig. 8 Nucleotides: Competitive insights
• Fig. 9 Parent market outlook
• Fig. 10 Related/ancillary market outlook
• Fig. 11 Penetration and growth prospect mapping
• Fig. 12 Industry value chain analysis
• Fig. 13 Nucleotides market driver impact
• Fig. 14 Nucleotides market restraint impact
• Fig. 15 Nucleotides market strategic initiatives analysis
• Fig. 16 Nucleotides market: Product movement analysis
• Fig. 17 Nucleotides market: Product outlook and key takeaways
• Fig. 18 Deoxy Nucleotides market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Dideoxynucleotides market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Labelled Nucleotides market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Nucleotides market: Technology movement analysis
• Fig. 23 Nucleotides market: Technology outlook and key takeaways
• Fig. 24 TaqMan allelic discrimination market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Gene chips & microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 SNP by pyrosequencing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Nucleotides market: Application movement analysis
• Fig. 29 Nucleotides market: Application outlook and key takeaways
• Fig. 30 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Diagnostics research market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Food & beverage additive market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Animal feed additive market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Global nucleotides market: Regional movement analysis
• Fig. 36 Global nucleotides market: Regional outlook and key takeaways
• Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Nucleotide Market Growth & Trends:

The global nucleotide market size is expected to reach USD 1,377.25 million by 2030, registering a CAGR of 7.12% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The global nucleotide market is expected to witness substantial growth over the forecast period owing to its widespread use in pharmaceuticals and food & beverage industries. Diagnostic research along with pharmaceutical applications dominated the nucleotide market owning to properties including enhanced immunity, positive effects on the intestines, and positive effects of recovery from stress. In addition, growing R&D in the field of dietary nucleotide coupled with yeast-derived nucleotide for livestock nutrition across the globe is expected to propel demand over the forecast period.

Nucleotide Market Report Highlights:

• The TaqMan allelic discrimination segment dominated the global market in 2022, followed by SNP by pyrosequencing
• The diagnostics research segment dominated the global market for nucleotides in 2022
• The deoxy nucleotides (dNTPs) segment dominated the global nucleotide market in 2022 with a revenue share of 47.49% and is furthermore likely to expand with the fastest CAGR of 7.34% over the forecast period
• Asia Pacific is expected to witness the fastest growth among other regions, growing at a CAGR of 7.81% from 2023 to 2030. The presence of the leading nucleotide manufacturer in the region coupled with increasing demand for nutraceuticals and the health food industry is expected to increase demand for the product. In addition, increasing food & beverage additive explorations particularly Asia Pacific is likely to propel market growth for nucleotide over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Technology
  • 1.1.3. Application
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Nucleotides Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Nucleotides Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Nucleotides Market: Product Estimates & Trend Analysis

• 4.1. Nucleotides Market: Key Takeaways
• 4.2. Nucleotides Market: Product Movement & Market Share Analysis, 2022 & 2030
• 4.3. Deoxy Nucleotides
  • 4.3.1. Deoxy Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.1.1. By production method
    • 4.3.1.1.1. Enzyme sourced
    • 4.3.1.1.2. Chemical synthesis
• 4.4. Dideoxynucleotides
  • 4.4.1. Dideoxynucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Nucleotides for RNA Synthesis (rNTP)
  • 4.5.1. Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Labelled Nucleotides
  • 4.6.1. Labelled Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Nucleotides Market: Technology Estimates & Trend Analysis

• 5.1. Nucleotides Market: Key Takeaways
• 5.2. Nucleotides Market: Technology Movement & Market Share Analysis, 2022 & 2030
• 5.3. TaqMan Allelic Discrimination
  • 5.3.1. TaqMan allelic discrimination market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Gene Chips & microarrays
  • 5.4.1. Gene chips & microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. SNP by Pyrosequencing
  • 5.5.1. SNP by pyrosequencing market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Nucleotides Market: Application Estimates & Trend Analysis

• 6.1. Nucleotides Market: Key Takeaways
• 6.2. Nucleotides Market: Application Movement & Market Share Analysis, 2022 & 2030
• 6.3. Pharmaceuticals
  • 6.3.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Diagnostics Research
  • 6.4.1. Diagnostics research market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Food & Beverage Additive
  • 6.5.1. Food & beverage additive market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Animal Feed Additive
  • 6.6.1. Animal feed additive market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Nucleotides Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Nucleotides Market by Region: Key Takeaways
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.3. France
    • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.6. Denmark
    • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. China
    • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.3. India
    • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. CJ CHEILJEDANG CORP
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Star Lake Bioscience Co., Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Thermo Fisher Scientific Inc.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. MEIHUA HOLDINGS GROUP CO., LTD.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. F. Hoffmann-La Roche Ltd.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Biorigin
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. DSM Nutritional Products AG
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Promega Corporation
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Agilent Technologies Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Lallemand Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Nanjing Biotogether Co., Ltd.
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. NuEra Nutraceuticals Inc.
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. Ohly
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives